Integra Lifesciences Holdings Corp (NASDAQ: IART) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Integra Lifesciences Holdings Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Integra Lifesciences Holdings Corp is $1.94B. A total of 0.71 million shares were traded on the day, compared to an average of 751.09K shares.

In the most recent transaction, Schwartz Eric sold 4,070 shares of IART for 24.59 per share on Dec 03 ’24. After the transaction, the EVP, Chief Legal Officer & Sec now owns 59,511 company shares. In a previous transaction on Dec 03 ’24, Schwartz Eric bought 4,070 shares at 24.59 per share.

Among the insiders who sold shares, McBreen Michael J. disposed of 1,700 shares on Dec 02 ’24 at a per-share price of $24.16. This resulted in the EVP & President, CSS holding 56,182 shares of IART after the transaction. In another insider transaction, Mosebrook Jeffrey sold 1,191 shares at $21.58 per share on Aug 19 ’24. Company shares held by the SVP, Fin & Princ Acct Officer now total 36,088.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IART has a high of $45.42 and a low of $16.81.

As of this writing, IART has an earnings estimate of $0.85 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.87 per share and a lower estimate of $0.84.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IART’s latest balance sheet shows that the firm has $513.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.65B in debt and $340.02M in liabilities at the time. Its Book Value Per Share was $19.73, while its Total Shareholder’s Equity was $1.68B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IART is Buy with a score of 2.82.

Most Popular

Related Posts